Detalhe da pesquisa
1.
A paradigm shift in understanding vulvovaginal melanoma as a distinct tumor type compared with cutaneous melanoma.
Gynecol Oncol
; 188: 13-21, 2024 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38861917
2.
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes.
Gynecol Oncol
; 184: 31-42, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277919
3.
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
Gynecol Oncol
; 184: 224-235, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340648
4.
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Gynecol Oncol
; 183: 103-114, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593674
5.
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement.
Lancet Oncol
; 24(10): e415-e423, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37797647
6.
A novel proteomic-based screening method for ovarian cancer using cervicovaginal fluids: A window into the abdomen.
Gynecol Oncol
; 164(1): 181-186, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756750
7.
Molecular profiles of endometrial cancer tumors among Black patients.
Gynecol Oncol
; 166(1): 108-116, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35490034
8.
Gemogenovatucel-T (Vigil) maintenance immunotherapy: 3-year survival benefit in homologous recombination proficient (HRP) ovarian cancer.
Gynecol Oncol
; 163(3): 459-464, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34702567
9.
Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer.
Gynecol Oncol
; 161(3): 676-680, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715892
10.
RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer.
Future Oncol
; 17(26): 3433-3443, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34409858
11.
Not immune to inequity: minority under-representation in immunotherapy trials for breast and gynecologic cancers.
Int J Gynecol Cancer
; 31(11): 1403-1407, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088749
12.
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
Lancet Oncol
; 21(12): 1661-1672, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33271095
13.
Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer.
Gynecol Oncol
; 156(2): 393-399, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31882243
14.
Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity.
Gynecol Oncol
; 157(3): 729-732, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173047
15.
Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
Gynecol Oncol
; 157(1): 67-77, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32029291
16.
Epigenetic basis of cancer health disparities: Looking beyond genetic differences.
Biochim Biophys Acta Rev Cancer
; 1868(1): 16-28, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28108348
17.
Intraperitoneal (IP) port cytology after completion of primary therapy for advanced stage ovarian cancer: A novel approach to a "second look".
Gynecol Oncol
; 154(2): 290-293, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160072
18.
Corrigendum to "Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer" [Gynecologic Oncology Volume 161, Issue 3, June 2021, Pages 676-680].
Gynecol Oncol
; 169: 173, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456375
19.
Values and worries of ovarian cancer patients.
Gynecol Oncol
; 147(2): 433-438, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28888542
20.
Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?
Gynecol Oncol
; 145(2): 329-333, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28215839